The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage
Nucleic Acids Research · 2024
DOI: 10.1093/nar/gkae004 ↗Kurz gefasst
Fachartikel in der Zeitschrift Nucleic Acids Research, 2024. Verfasst von Chao Jin und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology and Pulmonology, University Hospital Tübingen, Otfried-Müller-Str 14, 72076 Tübingen, Germany. Hauptthemen laut MEDLINE: DNA Damage. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: German Research Foundation, University Hospital Würzburg, University of Tübingen.
Abstract (Originalsprache)
DNA replication is a major source of endogenous DNA damage in tumor cells and a key target of cellular response to genotoxic stress. DNA replication can be deregulated by oncoproteins, such as transcription factor MYC, aberrantly activated in many human cancers. MYC is stringently regulated by the ubiquitin system - for example, ubiquitination controls recruitment of the elongation factor PAF1c, instrumental in MYC activity. Curiously, a key MYC-targeting deubiquitinase USP28 also controls cellular response to DNA damage via the mediator protein 53BP1. USP28 forms stable dimers, but the biological role of USP28 dimerization is unknown. We show here that dimerization limits USP28 activity and restricts recruitment of PAF1c by MYC. Expression of monomeric USP28 stabilizes MYC and promotes PAF1c recruitment, leading to ectopic DNA synthesis and replication-associated DNA damage. USP28 dimerization is stimulated by 53BP1, which selectively binds USP28 dimers. Genotoxic stress diminishes 53BP1–USP28 interaction, promotes disassembly of USP28 dimers and stimulates PAF1c recruitment by MYC. This triggers firing of DNA replication origins during early response to genotoxins and exacerbates DNA damage. We propose that dimerization of USP28 prevents ectopic DNA replication at transcriptionally active chromatin to maintain genome stability.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medical Oncology and Pulmonology, University Hospital Tübingen, Otfried-Müller-Str 14, 72076 Tübingen, Germany.
- DFG Cluster of Excellence 2180 'Image-guided and Functionally Instructed Tumor Therapies' (iFIT), University of Tübingen, Tübingen, Germany.
- Department of Radiation Oncology, University Hospital Würzburg, Josef-Schneider-Str. 2, 97080 Würzburg, Germany.
- Rudolf Virchow Center, Center for Integrative and Translational Bioimaging, University of Würzburg, Josef-Schneider-Str 2, 97080 Würzburg, Germany.
ORCID-Profile: Chao Jin, Elias Einig, Nikita Popov
Förderung
- German Research Foundation
- University Hospital Würzburg
- University of Tübingen
- University Hospital Tübingen
Zitieren
APA
Jin, C., Einig, E., Xu, W., Kollampally, R. B., Schlosser, A., Flentje, M., & Popov, N. (2024). The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage. Nucleic Acids Research. https://doi.org/10.1093/nar/gkae004
Vancouver
Jin C, Einig E, Xu W, Kollampally RB, Schlosser A, Flentje M, et al. The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage. Nucleic Acids Research. 2024. doi:10.1093/nar/gkae004
BibTeX
@article{Jin2024,
author = {Jin, Chao and Einig, Elias and Xu, Wenshan and Kollampally, Ravi Babu and Schlosser, Andreas and Flentje, Michael and Popov, Nikita},
title = {The dimeric deubiquitinase USP28 integrates 53BP1 and MYC functions to limit DNA damage},
journal = {Nucleic Acids Research},
year = {2024},
doi = {10.1093/nar/gkae004}
}
EUVIMED